This is the first study to investigate ERK1/2 and MEK1/2 MAPK intracellular signalling in CD56dimCD16+ and CD56brightCD16dim/− NK cell phenotypes in CFS/ME. This evidence concerns the gene MAP2K1 and myalgic encephalomeyelitis/chronic fatigue syndrome.